1 day ago - Translate

https://www.selleckchem.com/pr....oducts/delamanid.htm
7%) than the lesions without HBP findings (42.9%) (  = 0.002) and a low overall recurrence-free curve using the Kaplan-Meier method (  = 0.038). Using EOB-MRI/US FI as guidance, there was no difference in the recurrence rate between the groups with and without HBP findings (  = 0.799). In lesions with HBP findings, RFA guided by EOB-MRI/US FI (53.8%) produced a lower recurrence rate than CEUS/US (84.0%) (  = 0.045). The intraprocedurally application of EOB-MRI/US FI to determine ablation scope according to HBP findings is feasible and